Morgan Stanley Biomerica Inc Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Biomerica Inc stock. As of the latest transaction made, Morgan Stanley holds 315 shares of BMRA stock, worth $103. This represents 0.0% of its overall portfolio holdings.
Number of Shares
315
Previous 565
44.25%
Holding current value
$103
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding BMRA
# of Institutions
28Shares Held
1.79MCall Options Held
53.7KPut Options Held
0-
Granahan Investment Management, LLC Waltham, MA527KShares$174,0620.01% of portfolio
-
Russell Investments Group, Ltd.225KShares$74,3930.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA169KShares$55,7730.0% of portfolio
-
Potomac Capital Management, Inc.168KShares$55,3410.37% of portfolio
-
Black Rock Inc. New York, NY149KShares$49,1960.0% of portfolio
About BIOMERICA INC
- Ticker BMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 13,427,700
- Market Cap $4.43M
- Description
- Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...